Efficacy of eculizumab in refractory life‐threatening warm autoimmune hemolytic anemia associated with chronic myelomonocytic leukemia. Issue 12 (17th August 2020)

• Record Type: Journal Article
• Authors: Gauchy, Anne‐Cécile; Hentzien, Maxime; Wynckel, Alain; de Marcellus, Victoire; Rodier, Cyrielle; Delmer, Alain; Quinquenel, Anne
• Is Part Of: Clinical case reports. Volume 8:Issue 12(2020)
• Page Start: 2641
• Page End: 2644
• Publication Date: 2020-08-17
• Subjects: chronic myelomonocytic leukemia -- eculizumab -- warm autoimmune hemolytic anemia; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.3250
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: Eculizumab may be considered as an emergency therapeutic option in refractory life‐threatening warm autoimmune hemolytic anemia especially if direct antiglobulin test is positive for both IgG and C3d and after failure of all conventional treatments. Abstract : Eculizumab may be considered as an emergency therapeutic option in refractory life‐threatening warm autoimmune hemolytic anemia especially if direct antiglobulin test is positive for both IgG and C3d and after failure of all conventional treatments.